Going concern
Filing comparison
PMV Pharmaceuticals, Inc. said management's plans alleviate substantial doubt about going concern
No substantial-doubt conclusion identified → Substantial doubt raised, alleviated by management's plans
This assessment does not assume the receipt of any proceeds from the exercise of the Common Stock Warrants. As a result, management has concluded that there is no longer substantial doubt about the Company’s ability to continue as a going concern as of the date of this Quarterly Report. The Company will need to obtain additional funding in the future to complete the development and potential commercialization of its product candidates. The Company expects to obtain such funding through public or private equity, convertible or debt financing or capital obtained in connection with strategic…
Evidence
- Blank check
- No
- Comparable
- Yes
- Current state
- doubt_alleviated
- Current state label
- Substantial doubt raised, alleviated by management's plans
- Direction
- escalated
- Located in
- going-concern note
- Prior filed
- 2026-08-14
- Prior form
- 10-Q
- Prior state
- none
- Prior state label
- No substantial-doubt conclusion identified
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.